| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |